| Term 
 
        | Are slow-acetylators common? Do rapid Acetylators exist? What are common drugs affected by acetylator type? |  | Definition 
 
        | Slow Acetylators: Yes, 50% of US Fast acetylators: Yes Hydralazine Isoniazid Sulfamethazine Dapsone |  | 
        |  | 
        
        | Term 
 
        | What drug is affected by alterations in the pseudoplasmaesterases? Is a defect in pseudoplasma esterases common? How do you test for the mutation? Is it commonly tested for? |  | Definition 
 
        | Succynyl Choline Not common: 0.04% Test: Dibucaine inhibits by mutated protein less Not commoly tested, only asked in the history   |  | 
        |  | 
        
        | Term 
 
        | What are the drugs metabolized by CYP2D6? What are some things to consider before starting a drug metabolized by CYP2D6 with a patient having a mutation? What is the effect of the mutation on codiene? |  | Definition 
 
        | Antidepressants Anti-Psychotics Beta-Blockers Anti-Arrythmics Opiods Factors to consider Therapeudic Index Competitive inhibition of other drugs metabolized by the CYP2D6 Risks of Inducing Saturable Kinetics Codiene: Less effect |  | 
        |  | 
        
        | Term 
 
        | Mutation in CYP2C19 would effect what drugs? What population is it highest in? |  | Definition 
 
        | Mephenytoin Clopidogrel Population: asians |  | 
        |  | 
        
        | Term 
 
        | What are common drugs metabolized by CYP2C9 |  | Definition 
 
        | Warfarin Phenytoin Losartan Tolbutamide(Sulfonylurea for DM)   |  | 
        |  | 
        
        | Term 
 
        | What is the significance of G-6-P deficiency in drug interactions? What populations is it associated with? |  | Definition 
 
        | Sulfonamides and Anti-Malarial cause hemolytic anemia in these patients Ethnicity: African or Mediterranean |  | 
        |  | 
        
        | Term 
 
        | What is the significance of TPMT Deficiency? |  | Definition 
 
        | Patients of Azathioprine cannot break down 6-mercaptopurine causing Myelosuppression Enhanced by Allupurinol bc alternative degradation occurs through xanthine oxidase   |  | 
        |  |